Back to all Programs

Past Event

Related Materials

Past Event

Salvador HIV Clinical Forum 2019

Pharmacology Considerations When Choosing INSTIs - David Back, PhD

Toxicity Considerations When Choosing INSTIs - Ian Frank, MD

Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhD

Experience with Dolutegravir in First-Line in Brazil - Ricardo Diaz, MD

Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MD

Role of INSTIs in HIV Prevention - Mauro Schechter, MD, PhD

Clinical Case - Fabianna Bahia, MD, PhD

INSTIs Use in Women at Child-Bearing Age: NTD Risks - Isabella Nóbrega, MD

INSTIs Use in Pediatrics - Jorge Pinto, MD, DSc

Time to Change the Paradigm: Two vs. Three Drugs - Estevão Nunes, MD

Treatment Options for HIV-TB Co-Infection - Carlos Brites, MD, PhD

Long Acting ARV: Drugs and Delivery Systems - David Back, PhD